Wordt geladen...
4CPS-159 Quality of life assessment and efficacy of secukinumab in plaque psoriasis disease
BACKGROUND: Secukinumab has demonstrated efficacy in moderate to severe plaque psoriasis (PP) by improving the Psoriasis Area and Severity Index (PASI), but patients’ quality of life is not always quantified in clinical trials. PURPOSE: To evaluate the efficacy of secukinumab in PP treatment and how...
Bewaard in:
| Gepubliceerd in: | Eur J Hosp Pharm |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Group
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535509/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.250 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|